Evidence map›Paper›PMID 30076830›Full record

ArticleExperimental neurology2018

Increased expression of toll-like receptor 3, an anti-viral signaling molecule, and related genes in Alzheimer's disease brains.

Douglas G Walker, Tiffany M Tang, Lih-Fen Lue

Abstract read
In one paragraph

Article in Experimental neurology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 51 citations in OpenAlex.

  1. Synthetic viral RNA mimetics induce neuronal loss through microglial phagocytosis.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Article
  2. Article
  3. Review
  4. Review
  5. Innate Immune Mechanisms in the Central Nervous System.Advances in experimental medicine and biology · 2025
    Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Frontiers in pharmacology · 2023
    Article
  19. Glial Cell-Mediated Neuroinflammation in Alzheimer's Disease.International journal of molecular sciences · 2022
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Douglas G WalkerMolecular Neuroscience Research Center, Shiga University of Medical Science, Otsu, Japan; Neurodegenerative Disease Research Center, Biodesign Institute, Arizona State University, Tempe, Arizona, USA; Banner Sun Health Research Institute, Sun City, Arizona, USA. Electronic address: walker@belle.shiga-med.ac.jp.
Tiffany M TangNeurodegenerative Disease Research Center, Biodesign Institute, Arizona State University, Tempe, Arizona, USA.
Lih-Fen LueNeurodegenerative Disease Research Center, Biodesign Institute, Arizona State University, Tempe, Arizona, USA; Banner Sun Health Research Institute, Sun City, Arizona, USA.
Arizona State University · USBanner Sun Health Research Institute · US

Funding

Research Education ComponentP30AG019610 · NIA · SUN HEALTH RESEARCH INSTITUTE · PI GONZALEZ HERNANDEZ, GRACIELA · 2001 to 2020
$32.5M
National Brain and Tissue Resource for Parkinson's Disease and Related DisordersU24NS072026 · NINDS · BANNER SUN HEALTH RESEARCH INSTITUTE · PI BEACH, THOMAS G · 2011 to 2015
$7.8M
Is Toll-like receptor-3 signaling involved in Alzheimer's disease?R21AG044068 · NIA · BANNER SUN HEALTH RESEARCH INSTITUTE · PI WALKER, DOUGLAS GORDON · 2012 to 2013
$441k
Are the suppressors of cytokine signaling involved in Alzheimer's disease?R21AG034409 · NIA · BANNER SUN HEALTH RESEARCH INSTITUTE · PI WALKER, DOUGLAS GORDON · 2010 to 2011
$397k
NIA NIH HHS P30 AG019610NIA NIH HHS R21 AG034409NIA NIH HHS R21 AG044068NINDS NIH HHS U24 NS072026
6 · The paper itself

Abstract

The focus of this study is the expression of Toll-like receptor-3 (TLR-3), a receptor for double-stranded RNA, in human brains affected by Alzheimer's disease (AD) pathology. Toll-like receptors are a family of pattern recognition molecules primarily involved in host defenses to microbial pathogens, but roles in neurodegenerative disease have also been shown, as amyloid beta (Aβ) can be a ligand for TLR-2 and -4 and α-synuclein for TLR-1 and TLR-2, while TLR-9 activation promotes Aβ removal. However, involvement of TLR-3 in AD has not been rigorously studied. Immunohistochemical analyses in human temporal cortical sections with a validated antibody for TLR-3 predominantly identified microglia, particularly strongly in cells associated with amyloid plaques, also brain vascular endothelial cells and subsets of astrocytes, but not neurons or p62-immunoreactive structures. Microglial TLR-3 colocalized with the endosomal/lysosomal marker CD68, which identifies phagocytic cells. Quantitative analyses of neuropathologically-staged human brain middle temporal gyrus samples using immunohistochemistry and mRNA expression methods demonstrated increased TLR-3 immunoreactivity and increased TLR-3 mRNA in AD compared to non-demented cases. There were significant positive correlations between TLR-3 mRNA levels and plaque or tangle loads in both series of samples. Increased expression of interferon beta (IFN-β) and interferon regulatory factor (IRF)-3 mRNA, two factors induced by TLR-3 signaling, were detected in the AD cases. Increased expression of TLR-4 and TLR-9 mRNA was also observed in these same samples, but not TLR-2. In vitro cultured human brain microglia responses to Aβ inflammatory activation were not altered by TLR-3 activation with activator polyinosinic;polycytidylic acid (poly I:C), while human brain endothelial cells showed reduction in responses when stimulated with both agents. Treatment of microglia with poly I:C did not increase their uptake and breakdown of Aβ.

Indexed as

AgedAged, 80 and overAlzheimer DiseaseAmyloid beta-PeptidesBrainCalcium-Binding ProteinsCase-Control StudiesCells, CulturedCytokinesDNA-Binding ProteinsEndothelial CellsGene ExpressionHEK293 CellsHumansMicrofilament ProteinsMicrogliaAIF1 protein, humanAmyloid beta-Peptidesamyloid beta-protein (1-42)Calcium-Binding ProteinsCytokinesDNA-Binding ProteinsMicrofilament ProteinsP62 protein, humanPeptide FragmentsPhosphopyruvate HydratasePoly I-CRNA-Binding ProteinsTLR3 protein, humanToll-Like Receptor 3Toll-Like ReceptorsImmunohistochemistryInflammationInterferon responsesMicrogliaNeuropathologyPhagocytosisPlaquesTangles

Identifiers

PMID30076830
PMCPMC6151184
OpenAlexW2885212324

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.